<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
#f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
#f1 { font-family:ff6,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
#f2 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
#f3 { font-family:sans-serif; font-weight:normal; font-style:normal; }
#f4 { font-family:sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff7; src: url("7.ttf"); }
#f5 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
#f6 { font-family:ff8,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
#f7 { font-family:ff4,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff5; src: url("5.ttf"); }
#f8 { font-family:ff5,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img id="background" style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page19.png">
<div class="txt" style="position:absolute; left:61px; top:54px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스(207940)</span></div>
<div class="txt" style="position:absolute; left:56px; top:145px;"><span id="f1" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 개발 진척도 빨라</span></div>
<div class="txt" style="position:absolute; left:189px; top:104px;"><span id="f6" style="font-size:10px;vertical-align:baseline;color:rgba(0,159,197,1);">2. 진전이 빠른 자회사 바이오에피스의 바이오시밀러 사업</span></div>
<div class="txt" style="position:absolute; left:189px; top:128px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,159,197,1);">1) 삼성그룹의 시장대응 능력을 다시 한번 입증</span></div>
<div class="txt" style="position:absolute; left:189px; top:145px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바이오시밀러는 경쟁사 제품들과 품질 측면에서는 차별화하기 힘들어 오리지널의 특허가</span></div>
<div class="txt" style="position:absolute; left:189px; top:159px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">만료되는 즉시 제품을 출시해야 시장에서 경쟁우위를 점할 수 있다. 디스플레이, 반도체,</span></div>
<div class="txt" style="position:absolute; left:189px; top:173px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">휴대폰 등에서 증명된 삼성그룹의 빠른 시장대응 능력은 바이오시밀러 산업에서도 진가를</span></div>
<div class="txt" style="position:absolute; left:189px; top:187px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">보여줄 것으로 예상한다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:216px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">동사는 자회사 바이오에피스를 통해 설립 4년 만에 2개의 바이오시밀러 제품(Enbrel,</span></div>
<div class="txt" style="position:absolute; left:189px; top:230px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">Remicade)을 유럽시장에 출시했다. 올해 1월에는 세 번째 제품(Lantus)으로 유럽 내 판</span></div>
<div class="txt" style="position:absolute; left:189px; top:244px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">매를 승인 받고 올해 4월 미국시장에서도 Remicade의 바이오시밀러의 판매허가를 취득한</span></div>
<div class="txt" style="position:absolute; left:189px; top:258px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">바 있다. 반면 동사보다 먼저 바이오시밀러 개발을 시작한 셀트리온의 경우 두 개의 제품</span></div>
<div class="txt" style="position:absolute; left:189px; top:273px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">(Remicade, Rituxan)을 출시했으며 근 시일 내에 한 개의 제품(Herceptin)의 출시가 예정</span></div>
<div class="txt" style="position:absolute; left:189px; top:287px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">되어 있다는 점을 감안하면 동사의 파이프라인 개발속도는 비교적 빠른 것으로 사료된다.</span></div>
<div class="txt" style="position:absolute; left:189px; top:315px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">높은 진입장벽의 바이오시밀러 산업에서 동사가 빠른 속도로 시장 내 지위를 높일 수 있</span></div>
<div class="txt" style="position:absolute; left:189px; top:329px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">었던 비결은 임상시간 단축이다. 일반적으로 바이오시밀러의 승인기간은 통상 최대 2년</span></div>
<div class="txt" style="position:absolute; left:189px; top:344px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">정도로 알려져 있는데 동사는 이 기간을 약 1년으로 단축시켰다. 동사는 제품허가에 대해</span></div>
<div class="txt" style="position:absolute; left:189px; top:358px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">철저히 사전조사하고 공정혁신을 통해 고품질의 제품을 개발하기 위해 노력하는 한편 임</span></div>
<div class="txt" style="position:absolute; left:189px; top:372px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">상시험수탁기관(Contract Research Organization, CRO)에 대한 의존도를 낮추기 위해</span></div>
<div class="txt" style="position:absolute; left:189px; top:386px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">업무를 전적으로 위임하는 대신 각국에 관리인력을 파견하고 파트너사와 긴밀히 교류하면</span></div>
<div class="txt" style="position:absolute; left:189px; top:400px;"><span id="f7" style="font-size:9px;vertical-align:baseline;color:rgba(0,0,0,1);">서 제품 개발허가 기간을 단축할 수 있었다.</span></div>
<div class="txt" style="position:absolute; left:58px; top:426px;"><span id="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">&lt;표 8&gt; 삼성바이오로직스, 셀트리온 바이오시밀러 파이프라인 비교</span></div>
<div class="txt" style="position:absolute; left:57px; top:459px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 오리지널</span></div>
<div class="txt" style="position:absolute; left:156px; top:442px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">삼성바이오로직스</span></div>
<div class="txt" style="position:absolute; left:212px; top:454px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">개발단계</span></div>
<div class="txt" style="position:absolute; left:157px; top:465px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">임상 1 상 임상 3 상 허가 신청</span></div>
<div class="txt" style="position:absolute; left:309px; top:459px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">파이프라인 오리지널</span></div>
<div class="txt" style="position:absolute; left:276px; top:465px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">허가 승인</span></div>
<div class="txt" style="position:absolute; left:57px; top:480px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB4 베네팔리 Enbrel</span></div>
<div class="txt" style="position:absolute; left:211px; top:480px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:290px; top:480px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(255,255,255,1);">유럽 </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P05 Enbrel</span></div>
<div class="txt" style="position:absolute; left:57px; top:500px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB2 플릭사비 Remicade</span></div>
<div class="txt" style="position:absolute; left:276px; top:500px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(255,255,255,1);">미국/유럽</span></div>
<div class="txt" style="position:absolute; left:309px; top:496px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P13</span></div>
<div class="txt" style="position:absolute; left:309px; top:504px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">램시마</span></div>
<div class="txt" style="position:absolute; left:346px; top:500px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Remicade</span></div>
<div class="txt" style="position:absolute; left:57px; top:519px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB5 임랄디 Humira</span></div>
<div class="txt" style="position:absolute; left:211px; top:519px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:251px; top:519px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:309px; top:519px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P17 Humira</span></div>
<div class="txt" style="position:absolute; left:57px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB3</span></div>
<div class="txt" style="position:absolute; left:102px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Herceptin</span></div>
<div class="txt" style="position:absolute; left:57px; top:558px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB8</span></div>
<div class="txt" style="position:absolute; left:102px; top:558px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Avastin</span></div>
<div class="txt" style="position:absolute; left:57px; top:573px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SAIT-101</span></div>
<div class="txt" style="position:absolute; left:57px; top:582px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Archigen Bio</span></div>
<div class="txt" style="position:absolute; left:102px; top:578px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Rituxan</span></div>
<div class="txt" style="position:absolute; left:211px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:251px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:191px; top:554px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:191px; top:562px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:191px; top:573px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:191px; top:582px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:309px; top:535px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P06</span></div>
<div class="txt" style="position:absolute; left:309px; top:543px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">허쥬마</span></div>
<div class="txt" style="position:absolute; left:309px; top:558px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P16</span></div>
<div class="txt" style="position:absolute; left:309px; top:573px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P10</span></div>
<div class="txt" style="position:absolute; left:309px; top:582px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">트룩시마</span></div>
<div class="txt" style="position:absolute; left:346px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Herceptin</span></div>
<div class="txt" style="position:absolute; left:346px; top:558px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Avastin</span></div>
<div class="txt" style="position:absolute; left:346px; top:578px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Rituxan</span></div>
<div class="txt" style="position:absolute; left:57px; top:597px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">SB9 루수두나 Lantus</span></div>
<div class="txt" style="position:absolute; left:251px; top:597px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:290px; top:597px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(255,255,255,1);">유럽 </span><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P15 Erbitux</span></div>
<div class="txt" style="position:absolute; left:309px; top:617px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">CT-P14 Synagis</span></div>
<div class="txt" style="position:absolute; left:58px; top:634px;"><span id="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">자료: 삼성바이오로직스, 셀트리온, 한국투자증권</span></div>
<div class="txt" style="position:absolute; left:408px; top:442px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">셀트리온</span></div>
<div class="txt" style="position:absolute; left:447px; top:454px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">개발단계</span></div>
<div class="txt" style="position:absolute; left:395px; top:465px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">임상 1 상 임상 3 상 허가 신청</span></div>
<div class="txt" style="position:absolute; left:509px; top:465px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">허가 승인</span></div>
<div class="txt" style="position:absolute; left:510px; top:500px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(255,255,255,1);">미국/유럽</span></div>
<div class="txt" style="position:absolute; left:446px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:485px; top:539px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:446px; top:578px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">미국</span></div>
<div class="txt" style="position:absolute; left:524px; top:578px;"><span id="f8" style="font-size:6px;vertical-align:baseline;color:rgba(255,255,255,1);">유럽</span></div>
<div class="txt" style="position:absolute; left:62px; top:801px;"><span id="f3" style="font-size:10px;vertical-align:baseline;color:rgba(127,127,127,1);">18</span></div>
</body>
</html>
